## Abstract We used nigericin, a K^+^/H^+^ exchanger, to test whether glucose transport in 3T3‐L1 adipocytes was modulated by changes in intracellular pH. Our results showed that nigericin increased basal but decreased insulin‐stimulated glucose uptake in a time‐ and dose‐dependent manner. Whereas
Fructose 2,6-bisphosphate and insulin stimulation of glycolysis in 3T3-L1 adipocytes
✍ Scribed by Valeria Vasta; Paola Bruni; Fabio Vannini; Marta Farnararo
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 588 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0020-711X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
It is well established that somatotropin (GH) antagonizes insulin action in vivo and that supraphysiologic concentrations of GH frequently result in insulin resistance and glucose intolerance. However, the demonstration of an anti-insulin activity by GH in vitro has been difficult. This study, there
## Abstract Tunicamycin, an antibiotic that inhibits protein glycosylation, elicited a rapid depletion of insulin binding activity at the surface of 3T3‐L1 adipocytes. Disappearance of insulin receptors occurred more rapidly in the presence of tunicamycin than when protein synthesis was inhibited b
## Abstract O‐linked __N__‐acetylglucosamine (O‐GlcNAc) protein modification has been implicated in the regulation of signaling pathways, cell function, and gene expression. Glutamine:fructose‐6‐phosphate amidotransferase‐1 (GFAT‐1) is the rate‐limiting enzyme in the hexosamine biosynthetic pathway
## Abstract In insulin‐sensitive 3T3‐L1 adipocytes, selenium stimulates glucose transport and antilipolysis and these actions of selenium, like insulin actions, are sensitive to wortmanin, an inhibitor of phosphatidylinositol‐3‐kinase (PI3K). Selenium stimulates PI3K activity that is sustained up t
## Abstract Acylation stimulating protein (ASP) stimulates triglyceride synthesis and glucose transport via its receptor C5L2. The aims were (i) to evaluate ASP response under insulin‐resistant conditions and (ii) to identify mechanisms of ASP resistance using 3T3‐L1 adipocytes and preadipocytes. O